Life after COVID-19: R WE going to help?
Author:
Affiliation:
1. Global Access, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, CH-4070, Basel, Switzerland
2. Cytel Ltd, Hamilton House, Mabledon Place, London WC1H 9BB, UK
Publisher
Future Medicine Ltd
Subject
Health Policy
Link
https://www.futuremedicine.com/doi/pdf/10.2217/cer-2020-0056
Reference17 articles.
1. Estimates of the severity of coronavirus disease 2019: a model-based analysis
2. The effect of human mobility and control measures on the COVID-19 epidemic in China
3. Temporal dynamics in viral shedding and transmissibility of COVID-19
4. Respiratory virus shedding in exhaled breath and efficacy of face masks
5. Avoidable flaws in observational analyses: an application to statins and cancer
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations;Current Medical Research and Opinion;2022-07-11
2. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment;Journal of Comparative Effectiveness Research;2021-07
3. Introducing Volume 10 of the Journal of Comparative Effectiveness Research;Journal of Comparative Effectiveness Research;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3